Matinas BioPharma Holdings, Inc. (MTNB) Free cash flow 2016–2023
Matinas BioPharma Holdings, Inc. (MTNB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$15.5MFY2023 · since FY2016: -$6.1M → -$15.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$15.5M | +22.7% |
| FY2022 | -$20.0M | -29.5% |
| FY2021 | -$15.5M | +10.9% |
| FY2020 | -$17.4M | -19.8% |
| FY2019 | -$14.5M | -33.5% |
| FY2018 | -$10.9M | +12.5% |
| FY2017 | -$12.4M | -102.7% |
| FY2016 | -$6.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice